Nektar Therapeutics
NKTR
#5683
Rank
ยฃ0.87 B
Marketcap
ยฃ42.97
Share price
0.67%
Change (1 day)
261.59%
Change (1 year)

Nektar Therapeutics (NKTR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ0.16 Billion

According to Nektar Therapeutics 's latest financial reports the company's total liabilities are ยฃ0.16 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Nektar Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ0.19 B-7.58%
2023-12-31ยฃ0.20 B-26.27%
2022-12-31ยฃ0.28 B-12.32%
2021-12-31ยฃ0.32 B-4.23%
2020-12-31ยฃ0.33 B-22.38%
2019-12-31ยฃ0.43 B27.99%
2018-12-31ยฃ0.34 B9.39%
2017-12-31ยฃ0.31 B-20.04%
2016-12-31ยฃ0.38 B17.3%
2015-12-31ยฃ0.33 B27.59%
2014-12-31ยฃ0.26 B-18.12%
2013-12-31ยฃ0.31 B14%
2012-12-31ยฃ0.27 B6.05%
2011-12-31ยฃ0.26 B-5.71%
2010-12-31ยฃ0.27 B-4.61%
2009-12-31ยฃ0.29 B15.7%
2008-12-31ยฃ0.25 B-1.69%
2007-12-31ยฃ0.25 B-6.95%
2006-12-31ยฃ0.27 B-10.41%
2005-12-31ยฃ0.30 B113.26%
2004-12-31ยฃ0.14 B-42.85%
2003-12-31ยฃ0.25 B1.45%
2002-12-31ยฃ0.24 B-8.9%
2001-12-31ยฃ0.27 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
ยฃ60.40 B 37,133.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ86.74 B 53,370.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ58.24 B 35,800.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
ยฃ30.52 M-81.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ51.37 B 31,567.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
ยฃ10.39 B 6,305.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
ยฃ0.44 B 175.63%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
ยฃ85.17 B 52,400.91%๐Ÿ‡บ๐Ÿ‡ธ USA